Joshua A. Kazam - 10 Jun 2021 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
11 Jun 2021, 17:43:06 UTC
Previous filing
07 Jun 2021
Next filing
23 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +16,498 +2.3% $0.000000 743,885 10 Jun 2021 Direct
transaction ALLO Common Stock Gift $0 -500,000 -67% $0.000000 243,885 11 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 11, 2021, the reporting person transferred 500,000 shares of common stock to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.